QT Imaging Holdings, Inc.
QT Imaging Holdings, Inc. is dedicated to the research, development, and manufacturing of advanced automated systems for breast imaging. These innovative devices are engineered to generate high-resolution ultrasound images utilizing transmission technology. The company's core product, the QT Ultrasound Breast Scanner,…
1D
+0.8%
1W
-10.4%
1M
-7.0%
6M
-65.4%
YTD
-60.7%
1Y
+6.7%
2Y
+275.0%
5Y
–
10Y
–
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~22% weaker price swings than usual
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BearishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
PRICE TARGET LOW
US$8.00
CONSENSUS
US$8.00
MEDIAN
US$8.00
PRICE TARGET HIGH
US$8.00
No current analyst ratings available.
P/E
-2.05
P/B
15.85
EV/EBITDA
-1.9
RETURN ON EQUITY
-492.9%
NET MARGIN
-148.9%
DEBT/EQUITY
1.93
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
55.6%
FLOAT SHARES
8,134,864
AVG. DAILY VOLUME (30D)
32,422
Dinu Raluca
TIMM BRYAN
QT Imaging Holdings, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Raluca Dinu, the company employs around 32 people.
The IPO was on 05/03/2024; the stock trades on NASDAQ under the ticker QTI.
The average price target is US$8.00, ranging from US$8.00 to US$8.00, with a median of US$8.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly -22% stronger than usual.
No, QT Imaging Holdings currently does not pay a dividend.
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
Clicking "Analyze stock" lets five strategies assess QT Imaging Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.